Novelix signs technology transfer agreement with Germany-based GMBU for production of Astaxanthin
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
Cagrilintide represents a novel approach to obesity management
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
Subscribe To Our Newsletter & Stay Updated